DCF — NYU LANGONE HOSPITALS
Enterprise Value: $-9.3B
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-9.3B
Enterprise Value
$-3.0B
PV of Cash Flows
$-6.3B
PV of Terminal Value
$-10.1B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $7.5B | $-547.7M | -7.0% | $-863.4M | $-784.9M |
| Year 2 | $7.7B | $-487.3M | -6.0% | $-812.4M | $-671.4M |
| Year 3 | $7.9B | $-422.8M | -5.0% | $-757.7M | $-569.3M |
| Year 4 | $8.1B | $-394.7M | -5.0% | $-739.7M | $-505.2M |
| Year 5 | $8.4B | $-385.6M | -5.0% | $-740.9M | $-460.0M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-9.3B. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$7.2B
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.0784323463241966
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5